Insider Trades44 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Sell | CADL | Seshu Tyagarajan | Chief Technology Officer | 7,000 | $10.02 | $806.9M | -24.68% | +142.41% | $70.2K | -7.70% | 10b5-1 | Stalk |
| Jun 29, 2026 | Sell | CADL | Francesca Barone | Chief Scientific Officer | 23,447 | $10.06 | $806.9M | -24.68% | +142.41% | $235.8K | -23.26% | 10b5-1 | Stalk |
| Jul 28, 2025 | Sell | CADL | William Garrett Nichols | Chief Medical Officer | 1,874 | $4.13 | $806.9M | -24.68% | +142.41% | $7.7K | +0.00% | 10b5-1 | Stalk |
| Jun 30, 2025 | Sell | CADL | William Garrett Nichols | Chief Medical Officer | 1,562 | $3.17 | $806.9M | -24.68% | +142.41% | $4.9K | +0.00% | 10b5-1 | Stalk |
| Jun 25, 2025 | Buy | CADL | Francesca Barone | Chief Scientific Officer | 4,282 | $4.67 | $806.9M | -24.68% | +142.41% | $20.0K | +4.44% | — | Stalk |
| Jun 25, 2025 | Buy | CADL | Charles Schoch | Chief Financial Officer | 5,353 | $4.67 | $806.9M | -24.68% | +142.41% | $25.0K | +14.07% | — | Stalk |
| Jun 25, 2025 | Buy | CADL | Seshu Tyagarajan | Chief Technology Officer | 5,353 | $4.67 | $806.9M | -24.68% | +142.41% | $25.0K | +6.26% | — | Stalk |
| Jun 25, 2025 | Buy | CADL | Paul Peter Tak | Chief Executive Officer | 42,826 | $4.67 | $806.9M | -24.68% | +142.41% | $200.0K | +18.97% | — | Stalk |
| Mar 18, 2025 | Sell | CADL | Paul Peter Tak | Chief Executive Officer | 26,172 | $8.77 | $806.9M | -24.68% | +142.41% | $229.6K | -5.47% | 10b5-1 | Stalk |
| Mar 18, 2025 | Sell | CADL | Francesca Barone | Chief Scientific Officer | 50,146 | $6.17 | $806.9M | -24.68% | +142.41% | $309.6K | -5.24% | 10b5-1 | Stalk |
| Mar 18, 2025 | Sell | CADL | William Garrett Nichols | Chief Medical Officer | 63,805 | $6.77 | $806.9M | -24.68% | +142.41% | $432.1K | -5.50% | 10b5-1 | Stalk |
| Mar 17, 2025 | Sell | CADL | Charles Schoch | — | 5,000 | $8.83 | $806.9M | -24.68% | +142.41% | $44.2K | -11.62% | 10b5-1 | Stalk |
| Mar 17, 2025 | Sell | CADL | Seshu Tyagarajan | Chief Technology Officer | 31,278 | $8.82 | $806.9M | -24.68% | +142.41% | $275.9K | -16.75% | 10b5-1 | Stalk |
| Mar 17, 2025 | Sell | CADL | Seshu Tyagarajan | Chief Technology Officer | 51,278 | $5.88 | $806.9M | -24.68% | +142.41% | $301.7K | -3.98% | 10b5-1 | Stalk |
| Jan 15, 2025 | Sell | CADL | Charles Schoch | — | 9,511 | $7.22 | $806.9M | -24.68% | +142.41% | $68.7K | -18.10% | — | Stalk |
| Jan 15, 2025 | Sell | CADL | William Garrett Nichols | Chief Medical Officer | 10,428 | $7.23 | $806.9M | -24.68% | +142.41% | $75.3K | -11.62% | — | Stalk |
| Jan 15, 2025 | Sell | CADL | Francesca Barone | Chief Scientific Officer | 13,534 | $7.22 | $806.9M | -24.68% | +142.41% | $97.8K | -10.90% | — | Stalk |
| Jan 15, 2025 | Sell | CADL | Seshu Tyagarajan | Chief Technology Officer | 14,322 | $7.22 | $806.9M | -24.68% | +142.41% | $103.5K | -12.89% | — | Stalk |
| Jan 15, 2025 | Sell | CADL | Paul Peter Tak | Chief Executive Officer | 21,704 | $7.22 | $806.9M | -24.68% | +142.41% | $156.8K | -7.93% | — | Stalk |
| Jan 8, 2025 | Sell | CADL | Charles Schoch | — | 9,971 | $8.22 | $806.9M | -24.68% | +142.41% | $81.9K | -15.95% | — | Stalk |
| Jan 8, 2025 | Sell | CADL | William Garrett Nichols | Chief Medical Officer | 10,799 | $8.22 | $806.9M | -24.68% | +142.41% | $88.7K | -10.74% | — | Stalk |
| Jan 8, 2025 | Sell | CADL | Francesca Barone | Chief Scientific Officer | 13,673 | $8.22 | $806.9M | -24.68% | +142.41% | $112.4K | -9.92% | — | Stalk |
| Jan 8, 2025 | Sell | CADL | Seshu Tyagarajan | Chief Technology Officer | 14,545 | $8.22 | $806.9M | -24.68% | +142.41% | $119.5K | -11.58% | — | Stalk |
| Jan 8, 2025 | Sell | CADL | Paul Peter Tak | Chief Executive Officer | 21,172 | $8.22 | $806.9M | -24.68% | +142.41% | $174.0K | -7.18% | — | Stalk |
| Nov 29, 2024 | Sell | CADL | William Garrett Nichols | Chief Medical Officer | 13,935 | $4.56 | $806.9M | -24.68% | +142.41% | $63.5K | -12.17% | — | Stalk |
| Nov 29, 2024 | Sell | CADL | Seshu Tyagarajan | Chief Technology Officer | 20,392 | $4.56 | $806.9M | -24.68% | +142.41% | $92.9K | -13.96% | — | Stalk |
| Nov 29, 2024 | Sell | CADL | Francesca Barone | Chief Scientific Officer | 22,081 | $4.56 | $806.9M | -24.68% | +142.41% | $100.6K | -13.80% | — | Stalk |
| Nov 29, 2024 | Sell | CADL | Paul Peter Tak | Chief Executive Officer | 48,847 | $4.56 | $806.9M | -24.68% | +142.41% | $222.5K | -14.21% | — | Stalk |
| Nov 21, 2024 | Buy | CADL | Paul Peter Tak | Chief Executive Officer | 12,900 | $1.55 | $806.9M | -24.68% | +142.41% | $20.0K | +0.62% | — | Stalk |
| Jul 17, 2024 | Sell | CADL | Charles Schoch | — | 9,884 | $6.47 | $806.9M | -24.68% | +142.41% | $64.0K | -13.65% | — | Stalk |
| Jul 17, 2024 | Sell | CADL | William Garrett Nichols | Chief Medical Officer | 10,875 | $6.47 | $806.9M | -24.68% | +142.41% | $70.4K | -8.68% | — | Stalk |
| Jul 17, 2024 | Sell | CADL | Francesca Barone | Chief Scientific Officer | 14,051 | $6.47 | $806.9M | -24.68% | +142.41% | $90.9K | -8.07% | — | Stalk |
| Jul 17, 2024 | Sell | CADL | Seshu Tyagarajan | Chief Technology Officer | 14,851 | $6.47 | $806.9M | -24.68% | +142.41% | $96.1K | -9.23% | — | Stalk |
| Jul 17, 2024 | Sell | CADL | Paul Peter Tak | Chief Executive Officer | 22,528 | $6.47 | $806.9M | -24.68% | +142.41% | $145.8K | -6.38% | — | Stalk |
| Jul 11, 2024 | Sell | CADL | Charles Schoch | — | 8,897 | $5.97 | $806.9M | -24.68% | +142.41% | $53.1K | -10.94% | — | Stalk |
| Jul 11, 2024 | Sell | CADL | William Garrett Nichols | Chief Medical Officer | 9,769 | $5.97 | $806.9M | -24.68% | +142.41% | $58.4K | -7.23% | — | Stalk |
| Jul 11, 2024 | Sell | CADL | Francesca Barone | Chief Scientific Officer | 12,645 | $5.97 | $806.9M | -24.68% | +142.41% | $75.5K | -6.77% | — | Stalk |
| Jul 11, 2024 | Sell | CADL | Seshu Tyagarajan | Chief Technology Officer | 13,330 | $5.97 | $806.9M | -24.68% | +142.41% | $79.6K | -7.65% | — | Stalk |
| Jul 11, 2024 | Sell | CADL | Paul Peter Tak | Chief Executive Officer | 20,293 | $5.97 | $806.9M | -24.68% | +142.41% | $121.2K | -5.43% | — | Stalk |
| Nov 28, 2023 | Sell | CADL | William Garrett Nichols | Chief Medical Officer | 12,175 | $0.90 | $806.9M | -24.68% | +142.41% | $11.0K | -8.27% | — | Stalk |
| Nov 28, 2023 | Sell | CADL | Seshu Tyagarajan | Chief Technology Officer | 17,328 | $0.90 | $806.9M | -24.68% | +142.41% | $15.6K | -9.05% | — | Stalk |
| Nov 28, 2023 | Sell | CADL | Francesca Barone | Chief Scientific Officer | 19,748 | $0.90 | $806.9M | -24.68% | +142.41% | $17.8K | -9.57% | — | Stalk |
| Nov 28, 2023 | Sell | CADL | Jason Amello | Chief Financial Officer | 20,153 | $0.90 | $806.9M | -24.68% | +142.41% | $18.1K | -9.07% | — | Stalk |
| Nov 28, 2023 | Sell | CADL | Paul Peter Tak | Chief Executive Officer | 43,443 | $0.90 | $806.9M | -24.68% | +142.41% | $39.1K | -10.42% | — | Stalk |